Article Versions Notes

Moretti IF, Lerario AM, Sola PR, Macedo-da-Silva J, Baptista MdS, Palmisano G, Oba-Shinjo SM, Marie SKN. GBM Cells Exhibit Susceptibility to Metformin Treatment According to TLR4 Pathway Activation and Metabolic and Antioxidant Status. Cancers. 2023; 15(3):587. https://doi.org/10.3390/cancers15030587

Moretti, Isabele Fattori, Antonio Marcondes Lerario, Paula Rodrigues Sola, Janaína Macedo-da-Silva, Mauricio da Silva Baptista, Giuseppe Palmisano, Sueli Mieko Oba-Shinjo, and Suely Kazue Nagahashi Marie. 2023. "GBM Cells Exhibit Susceptibility to Metformin Treatment According to TLR4 Pathway Activation and Metabolic and Antioxidant Status" Cancers 15, no. 3: 587. https://doi.org/10.3390/cancers15030587

Moretti, I. F., Lerario, A. M., Sola, P. R., Macedo-da-Silva, J., Baptista, M. d. S., Palmisano, G., Oba-Shinjo, S. M., & Marie, S. K. N. (2023). GBM Cells Exhibit Susceptibility to Metformin Treatment According to TLR4 Pathway Activation and Metabolic and Antioxidant Status. Cancers, 15(3), 587. https://doi.org/10.3390/cancers15030587